Impact of Multidisciplinary Program on Falls in Elderly Inpatients

Overview

Falls among elderly inpatients are common, multifactorial and associated with a significant increase of complications and morbidity. According to a recent Cochrane review, the effectiveness of fall prevention program has been assessed in community-dwelling and in long stay wards but not in rehabilitation wards (RW) and geriatric acute wards (GAW). IPR study aims to measure the impact of a multidisciplinary prevention program on falls in elderly inpatients.

Full Title of Study: “A Multidisciplinary Program for Preventing Falls “Identify, Prevent and Get up”: Impact on Falls in Elderly Inpatients”

Study Type

  • Study Type: Interventional
  • Study Design
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2014

Interventions

  • Other: The multidisciplinary prevention program called “IPR” (in French “Identifier, PrĂ©venir, Relever”)
    • The intervention is a multidisciplinary program of fall prevention including 3 complementary interventions which focus on several stages of elderly inpatient management: Identification of patient’s fall risk, Multifactorial fall prevention program (integrated actions targeted on risk factors, exercise programs and review of the hospital environment), “Get up” workshop and morbidity and mortality conferences related to fall cases

Arms, Groups and Cohorts

  • Other: Usual care

Clinical Trial Outcome Measures

Primary Measures

  • Incidence of falls among elderly inpatients
    • Time Frame: patients will be followed for the duration of hospital stay, 15 months maximum

Secondary Measures

  • Incidence of fall-related mortality
    • Time Frame: patients will be followed for the duration of hospital stay, 15 months maximum
  • Incidence of fall-related
    • Time Frame: patients will be followed for the duration of hospital stay, 15 months maximum

Participating in This Clinical Trial

Inclusion Criteria

  • Male or female subject aged over 65 years
  • Admitted during the study
  • Participation agreement

Exclusion Criteria

  • Patients with a MMSE<10 and incapable to participate to a reeducation program
  • Patient with an evolutionary andor badly checked psychiatric pathology
  • Bedridden patient

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospices Civils de Lyon
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Pierre KROLAK-SALMON, Principal Investigator, Hospices Civils de Lyon

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.